GESTATIONAL HYPERTENSION AND PREVENTION OF PERINATAL COMPLICATIONS IN PREGNANT WOMEN

Authors

  • Ch.T. Shokirova Andijan State Medical Institute Author
  • F J. Nasirova Andijan State Medical Institute Author
  • Sh.T. Ismoilova PhD in Medical Sciences, Obstetrician-Gynecologist, Fergana State Medical Organization (FSMO), Maternity Hospital Author

Abstract

Gestational hypertension (GH), a form of high blood pressure occurring after 20 weeks of gestation, is a common condition that affects approximately 5-10% of pregnancies globally. This condition is associated with significant maternal and perinatal risks, including preeclampsia, placental abruption, preterm delivery, and intrauterine growth restriction (IUGR). The increasing prevalence of GH, particularly in populations with higher rates of obesity and metabolic syndrome, underscores the necessity for proactive management and prevention strategies to reduce adverse outcomes.

References

ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology, 2019.

Magee, L. A., et al. (2014). Management of hypertension in pregnancy. BMJ, 349, g5332.

Sibai, B. M. (2003). Diagnosis and management of gestational hypertension and preeclampsia. Obstetrics & Gynecology, 102(1), 181-192.

World Health Organization. (2022). WHO recommendations for prevention and treatment of preeclampsia and eclampsia.

National Institute for Health and Care Excellence (NICE). (2019). Hypertension in pregnancy: diagnosis and management.

Published

2025-01-16

How to Cite

GESTATIONAL HYPERTENSION AND PREVENTION OF PERINATAL COMPLICATIONS IN PREGNANT WOMEN. (2025). Natural Sciences in the Modern World, 4(1), 51-52. https://in-academy.uz/index.php/ZDTF/article/view/20041